Category: News and press

The Innovative Medicins Initiative (IMI) launched its 8th call for proposals.Topics included under the IMI programme “Combating Antibiotic Resistance: New Drugs for Bad Bugs” are:

• Topic 1C: Innovative Trial Design & Clinical Development
• Topic 3: Discovery and development of new drugs combating Gram – negative infections

Dealine for submitting a proposal is 19 March 2013.

Link: IMI 8th call for proposals 

About the Innovative Medicins Initiative:

The Innovative Medicines Initiative (IMI) is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

The Swedish government allocates a total of SEK 265 million over four years for research on infection and antibiotics. The initiative was announced in the Research and Innovation bill of 2013, outlining the Swedish government’s research policy and funding for 2013-2016.

In the bill, the Swedish government further states that:

“To strengthen the international competitiveness of Swedish research, the Government has used the following starting points for the assessments made in the bill:
• freedom, long-term approach and greater opportunities for risk-taking;
• greater possibilities to achieve high quality;
• good conditions for researchers;
• initiatives for society and business; and
• increased utilisation of research-based knowledge.”

Link: Research and Innovation – A summary of Government Bill 2012/13:30

A two-day conference on the results and experience coming from joint programming activities to date will take place in Dublin February 28–March 1, 2013. The conference is organised within the realms of the Irish presidency and is excpected to attract 300-500 participants. Conclusions drawn from the conference will be used to progress the ERA and the H2020 agendas.

Link: Joint Programming Conference, Dublin February 28 – March 1 2013